January 12, 2022 Annual Town Hall Member Meeting
You’re invited to join the Clinical TMS Society for the January 12, 2022 Annual Town Hall Member Meeting.
Join the Clinical TMS Society President Randy Pardell, MD, DLFAPA, Executive Director Ashleigh Sevadio and our current committee co-chairs for an update on all 2021-2022 committee projects.
This is your opportunity to learn more about the various goals and projects, ask questions and provide feedback.
Date: January 12, 2022
Format: Zoom Meeting
This meeting is for current members only.
John O'Reardon, MD, CTMSS Annual Meeting Committee Co-chair
Dr. O’Reardon has been in practice as a psychiatrist for 30 years. He completed his residency training at Penn and Fellowships in Psychopharmacology & Cognitive Therapy (including training at the Beck Institute). In his clinical work as a faculty member at Penn he focused on treatment-resistant mood disorders and neuromodulation. This is the development of brain devices to stimulate the brain and treat mood disorders. These devices, which are increasing all the time, include transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), EEG-synchronized TMS (sTMS), deep TMS (dTMS) and transcranial direct current stimulation (tDCS).
Dr. O’Reardon was an active educator at Penn and over the years helped train more than a hundred psychiatry residents. He taught courses on neuromodulation, mood disorders and the History of Psychiatry. He has been a recipient of numerous teaching awards including the Earl Bond Award for excellence in teaching. He has been a frequent presenter at the annual meeting of the American Psychiatric Association (APA). Most recently he has presented a symposium on historical figures and mood disorders called Art, Politics and Creativity: Resilience in the Face of Great Odds – including Abraham Lincoln, Vincent Van Gogh, Winston Churchill and Sylvia Plath.
Dr. O’Reardon has been an active and productive researcher during his career. He has authored over a hundred publications in his career encompassing new brain devices (TMS, sTMS, VNS, DBS and tDCS), major depression, bipolar disorder, ECT and the night eating syndrome. He has been a lead investigator in many cutting edge clinical trials of new treatments for patients. He is first author on the primary trial that led to FDA approval for TMS as new exciting treatment for major depression. His current research work is with another exciting emerging treatment modality for major depression, namely tDCS.
Robert Sammons, MD, CTMSS Annual Meeting Committee Co-chair
Dr. Bob Sammons received a bachelor's and master's degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill. He did a residency in psychiatry at the University of Virginia as well as a forensic psychiatry fellowship. While a Captain in the Air Force he helped set up and run the treatment phase of the Air Force Drug Treatment program in 1971. He has practiced adult psychiatry in Grand Junction for 29 years. He received training in TMS in 2006 from Dr. Alvaro Pascual-Leone, from Dr. Mark George in 2017 and returned to Harvard for Dr. Pascual-Leone's intensive course in TMS in 2018. He is Medical Director for TMS Solutions with TMS offices in various locations in the West.
Michelle Cochran, MD, CTMSS Education Committee Co-chair
Dr. Cochran received her undergraduate degree from Centre College in Danville, Kentucky, and completed her medical training at the University of Louisville School of Medicine. She received postgraduate medical education at Vanderbilt University Medical Center in Nashville, TN, where she completed a residency in Psychiatry. During this residency she was Chief Resident. Additionally, she completed the Management Program for Physicians and Senior Healthcare Administrators at Vanderbilt University's Owen School of Management. A diplomat of the American Board of Psychiatry and Neurology, Dr. Cochran is a member of the Tennessee Psychiatric Association, Tennessee Medical Association, Nashville Academy of Medicine, the Clinical TMS Society and Tennessee Women in Medicine. Since her residency years, she has been a member of the American Psychiatric Association, and in early 2011, she was inducted as a Fellow in this organization. Dr. Cochran has been on the Clinical Faculty in the Department of Psychiatry at Vanderbilt University Medical Center since 1996 and has lectured to undergraduate, graduate, and postgraduate students as well as private practitioners.
For over 20 years, she has been active on numerous advisory boards professionally and personally. Before retiring from inpatient psychiatric care and establishing her outpatient private practice, she was the medical director for many psychiatric units and programs in the Middle Tennessee area. Dr Cochran currently works in a private practice in Nashville. She has experience treating a variety of psychiatric conditions, using therapy, counseling, medicines, neuro-modulation, and integrative care options. Dr. Cochran and her staff have trained extensively in the use of repetitive Transcranial Magnetic Stimulation (rTMS) including training at Harvard (Berenson Allen Non-Invasive Brain Stimulation Clinic), Duke and other training. Dr Cochran has spoken nationally on the use of rTMS in a clinical setting in both industry and continuing education venues. Dr. Cochran has been a integral part of the Clinical TMS Society, currently serving on the Education & Annual Meeting Committees.
Martha Koo, MD, CTMSS Research Committee Co-chair
Dr. Martha B. Koo, M.D., completed her undergraduate studies at Princeton University and her medical training at the David Geffen School of Medicine at UCLA. She obtained her psychiatry residency training at the UCLA Resnick Neuropsychiatric Institute and her subsequent psychoanalytic training at the New Center for Psychoanalysis. She is double Board Certified in Psychiatry and Addiction Medicine. For over 25 years, Dr. Koo has enjoyed her private practice, providing outpatient psychotherapy, psychoanalysis and pharmacological treatment for individuals, couples and families. A pioneer in the development and application of Transcranial Magnetic Stimulation (TMS), Dr. Koo opened the South Bay TMS Therapy Center in 2009. She is currently the founder and CEO of Neuro Wellness Spa, where she offers TMS, Magnetic E-Resonance therapy, iv ketamine, iv nutrition, and photobiomodulation as novel interventions for treatment-resistant mental illness. In pursuit of additional interventions for wellness, she is currently studying psychedelic assisted psychotherapy at the California lnstitute of Integral Studies. Dr. Koo is also the Medical Director at Clear Recovery Center, a residential detox and intensive outpatient treatment center for individuals struggling with mental health, addiction and dual diagnoses. She is on the Board of Directors of the Clinical TMS Society and the Beach Cities Health District and is an active lecturer at the New Center for Psychoanalysis.
Saydra R Wilson, MD, CTMSS Outreach Committee Co-chair
Dr, Saydra Wilson is an Assistant Professor at the University of Minnesota-Twin Cities where she combines her clinical interventional psychiatry work in ECT and TMS with her research interests in TMS mechanisms and biomarkers for TMS response. She has been a member of the Clinical TMS Society since 2018 and is currently serving on the Board of Directors and enjoy's her role as Outreach committee co-chair and member of the Education Committee.
W. Nate Upshaw, MD, CTMSS Outreach Committee Co-chair
Dr. Upshaw began his medical training at the University of Florida and Tulane University School of Medicine. After attaining his doctorate at Tulane, Upshaw continued onto the University of South Florida School of Medicine, where he completed his internship and residency in Psychiatry. While at the University of South Florida, Dr. Upshaw, under the stewardship of a forward-thinking chairman, received training to practice TMS shortly after being FDA cleared in 2008. The department’s progressive approach eventually led to the university obtaining two of the first TMS chairs in the entire state of Florida.
F. Andrew Kozel, MD, MSCR, CTMSS Clinical Standards Committee Co-chair
Dr. Kozel is Professor and the Mina Jo Powell Endowed Chair for Neurological Sciences at Florida State University College of Medicine where he directs FSU Neuromodulation at Innovation Park, is the Medical Director for FSU Behavioral Health at Apalachee Center and Co-Director for the FSU Mood and Anxiety Center of Excellence in the Department of Behavioral Sciences and Social Medicine. Kozel's work with neuromodulation techniques like TMS has included research, clinical care, teaching, and dissemination for over 20 years. His research uses brain imaging and brain stimulation to better understand and treat neuropsychiatric disorders with the focus of improving the lives of patients with these devastating disorders.
Richard Bermudes, MD, CTMSS Insurance Committee Co-chair
Richard Bermudes, M.D., is the chief medical officer at Mindful Health Solutions in California and a volunteer assistant clinical professor of psychiatry at the University of California, San Francisco. He is a co-founder of the Clinical TMS Society, former president and board member and currently co-chairs the insurance committee. His clinical practice includes ECT, TMS, Ketamine and Esketamine. He has a column with Psychiatric News on Interventional Psychiatry and he is also the co-editor of Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice from APA Publishing.
Ken Goolsby, MD, CTMSS Membership Committee Co-chair
Kenneth E. Goolsby, M.D. has been in private practice in Gainesville since 1987. As a child, adolescent and adult psychiatrist, he provides diagnostic evaluations, individual and family psychotherapy, medication evaluation and management, crisis intervention, and chemical dependency evaluations. Dr. Goolsby provides inpatient hospital care as well as outpatient care.
Dr. Goolsby earned his bachelor's degree at the University of Georgia and his medical degree at the Medical College of Georgia. He completed his psychiatric residency at the William S. Hall Psychiatric Institute Emory University. He then completed his child psychiatry fellowship at William S. Hall Psychiatric Institute. He is a diplomate of the American Board of Psychiatry and Neurology.
Ian Cook, MD, CTMSS Legal, Business, and Ethics Committee Co-chair
Ian A. Cook, M.D. is Founder and Director of the Los Angeles TMS Institute, Inc., and Professor Emeritus of Psychiatry and Biobehavioral Sciences in UCLA’s David Geffen School of Medicine, where he previously held the Miller Family Endowed Chair in Depression Research, was Director of the UCLA Depression Research & Clinic Program, and was the Founding Director of the UCLA TMS Service. Dr. Cook earned his bachelors degree with high honors from Princeton University and his medical degree from the Yale University School of Medicine. He completed his psychiatry residency training at UCLA's Neuropsychiatric Institute, where he also was an NIMH-funded research fellow, before joining the faculty. Dr. Cook served on the Executive Committee on Practice Guidelines of the American Psychiatric Association and guided the electronic dissemination of their evidence-based guidelines in psychiatry. A board-certified Psychiatrist, he has also served as an examiner for the American Board of Psychiatry and Neurology. His biography is profiled in Who's Who in America, Who's Who in the World, and Best Doctors. He is the author of numerous publications on brain function in mental illness and in aging and holds several dozen patents on biomedical devices and methods.
Mahmound Okasha, MD, CTMSS Legal, Business, and Ethics Committee Co-chair
Dr. Mahmoud Okasha is a board certified psychiatrist. He has been in clinical practice since 1977. He became an Associate Clinical Professor of Psychiatry after completing his residency at Yale Medical School department of psychiatry. Dr. Okasha is the Medical Director of Comprehensive Psychiatric Care.
He has always been interested in research and began his career in London, England in 1970 where he was doing his residency in psychiatry at the Westminster Medical School. Dr. Okasha has been a primary investigator since 2000 at CPC where he has conducted numerous trials. He is also interested in clinical work with anxiety and treatment-resistant depression, which led to his initiation of TMS at CPC.
Randy Pardell, MD, DLFAPA CTMSS President
Dr. Pardell is currently the President of the Clinical TMS Society. He has served on the Board of Directors of CTMSS for the past 4 years and has been elected to the Executive Committee as Member at Large for two terms and now as President. He has been past Chairman of the Outreach Committee and has served on the Membership and Education Committees. He has been a returning lecturer for the CTMSS Pulses Course. He has been practicing TMS therapy since 2009. He co-wrote the first lay book on TMS called 3000 Pulses. Dr. Pardell is an honors graduate of the University of Pennsylvania and New York University School of Medicine. He completed his residency and chief residency at the St. Luke’s Roosevelt Medical Center and Post-Doctoral Fellowship at Columbia University where he performed smoking cessation research with Alexander Glassman MD. After graduation from his psychiatric training, Dr. Pardell moved up with his wife to the beautiful Hudson Valley, New York to start a practice and raise a family. Dr. Pardell is a Distinguished Life Fellow of the American Psychiatric Association and has been a past President of the Mid-Hudson Psychiatric Society and had been its Program Director for over a decade. Dr. Pardell founded Riverview Psychiatric Medicine, PC and TMS Center of the Hudson Valley and leads an active group psychiatric and TMS practice.